Can Eye-Tracking reveal if autism therapy is working?
NCT ID NCT05675371
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This completed study tested a device called EarliPoint that uses eye-tracking to monitor changes in children with autism spectrum disorder (ASD) or developmental delays. Researchers followed 325 children aged 15-84 months over 180 days to see if the device could detect improvements in verbal ability, non-verbal learning, and social disability. The goal was to see if this tool could help doctors track treatment progress more objectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EarliPoint System (eye-tracking device)
What this could lead to
If successful, this could provide a simple, objective way to measure how well autism treatments are working over time.
What could go wrong
This was an observational study, not a treatment trial. The device is still new, and it may not reliably track changes in all children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AJ Drexel Autism Institute, Drexel University
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Cortica - Glendale
Glendale, California, 91203, United States
-
Cortica - Marin
San Rafael, California, 94903, United States
-
Cortica - Torrance
Torrance, California, 90503, United States
-
Cortica - Weslake Village
Westlake Village, California, 91361, United States
-
Emory University/Marcus Autism Center
Atlanta, Georgia, 30329, United States
-
Munroe-Meyer Institute / University of Nebraska
Omaha, Nebraska, 68106, United States
-
Southwest Autism Research and Resource Center (SARRC)
Phoenix, Arizona, 85006, United States